 All the patients signed an institutional informed consent form before the harvest of peripheric stem cells PROMISE program. Patients received Neupogen Amgen-SA between April 2008 and February 2010, and the next group of patients was treated with Ratiograstim Ratiopharm GmbH until May 2012. The last group of patients received Zarzio Sandoz GmbH until November 2014. 